Indole Derivatives and Use Thereof as Kinase Inhibitors in Particular Ikk2 Inhibitors

1 . A compound of Formula (I):

wherein R 1 represents H, halogen, or a group —YZ;

Y represents a bond (i.e. is absent), C 1-6 alkylene or C 2-6 alkenylene;

Z represents an aryl or heteroaryl group each comprising 5-14 ring members, said aryl or heteroaryl being optionally substituted by one or more substituents independently selected from halogen, OH, C 1-6 alkyl, C 1-6 haloalkyl, C 1-6 alkoxy, C 1-6 haloalkoxy, CN, C 1-6 hydroxyalkyl, phenyl, O—(CH 2 ) 1-6 -phenyl, NHSO 2 R 3 , NHCOR 3 , CONR 4 R 5 , SO 2 NR 4 R 5 ;

R 3 , R 4 and R 5 independently represent H or C 1-6 alkyl;

R 2 represents H, halogen or a group —Y 1 Z 1 ;

Y 1 represents a bond (i.e. is absent), C 1-6 alkylene, C 2-6 alkenylene;

Z 1 represents a 6 membered aryl, 5 or 6 membered heteroaryl, 5-7 membered heterocyclyl, C 5-7 cycloalkyl, C 5-7 cycloalkenyl, each of which may be optionally substituted by one or more substituents independently selected from SO 2 R 6 , NHSO 2 R 6 ,

COR 7 ,NR 7 R 8 , SO 2 NR 7 R 8 , C 1-6 alkyl, C 1-6 haloalkyl, C 1-6 alkoxy, C 1-6 haloalkoxy, halogen, CONR 7 R 8 , NHCOR 7 , or phenyl (directly attached or attached by a C 1-6 alkylene, CONH, C 2-6 alkenylene spacer and optionally substituted by one or more substituent selected from

C 1-6 alkyl, C 1-6 alkoxy, C 1-6 haloalkyl, C 1-6 haloalkoxy, OH, halogen);

R 6 represents H, C 1-6 alkyl, —(CH 2 ) n phenyl or —(CH 2 ) n napthyl (where n is 0 or 1 and each of which phenyl or naphthyl may be optionally substituted by one or more substitutents independently selected from C 1-6 alkyl, C 1-6 alkoxy, halogen, NR 7 R 8 , C 1-6 haloalkyl, C 1-6 haloalkoxy), CN or —(O) p phenyl (where p is 0 or 1 and the phenyl is optionally substituted by one or more substitutents independently selected from halogen, C 1-6 alkyl or C 1-6 alkoxy)):

R 7 and R 8 independently represents C 1-6 alkyl, H, C 1-6 alkylene NR 9 R 10 ;

R 9 and R 10 independently represents C 1-6 alkyl, H;

with the proviso R 1 and R 2 do not both represent H;

or a salt, solvate, or physiologically functional derivative thereof.

2 . A compound according to claim 1 wherein R 1 is YZ.

3 . A compound according to claim 2 wherein Y is a bond or —CH ═CH—.

4 . A compound according to claim 3 wherein Y is a bond.

5 . A compound according to claim 1 wherein Z is phenyl (which may be unsubstituted or substituted once or twice by substituents independently selected from C 1-3 alkoxy, CN, OH, phenyl, —OCH 2 phenyl NHSO 2 R 3 , NHCOR 3 , CONR 4 R 5 , SO 2 NR 4 R 5 , halogen, C 1-3 hydroxyalkyl, C 1-4 alkyl) or a heteroaryl group selected from benzofuranyl, quinolinyl,

pyrimidinyl, thiophenyl, isoxazolyl, pyridinyl (each of which may be optionally substituted by one or two groups independently selected from C 1-3 alkyl, C 1-3 alkoxy, halogen.

6 . A compound according to claim 5 wherein Z is phenyl (which is unsubstituted or substituted once by a substituent selected from phenyl, OCH 2 phenyl, NHSO 2 CH 3 , NHCOCH 3 , CONH 2 , CON(CH 3 ) 2 , Cl, F, OCH 3 , CN, OH, CH 2 OH, CH 3 , C(CH 3 ) 3 ) or a heterocyclic group selected from benzofuranyl, quinolinyl,

pyrimidinyl, thiophenyl, benzothiophenyl, isoxazolyl, pyridinyl (each of which is substituted or is substituted once by a group selected from —OCH 3 , CH 3 , F).

7 . A compound according to claim 6 wherein Z is phenyl (which is unsubstituted or substituted once by a substituent selected from phenyl, OCH 2 phenyl, NHSO 2 CH 3 , NHCOCH 3 , CONH 2 , CON(CH 3 ) 2 , Cl, F, OCH 3 , CN, OH, CH 2 OH, CH 3 , C(CH 3 ) 3 ).

8 . A compound according to claim 7 wherein Z is phenyl.

9 . A compound according to claim 1 wherein R 2 is H or Y 1 Z 1 .

10 . A compound according to claim 9 wherein R 2 is Y 1 Z 1 .

11 . A compound according to claim 10 wherein Y 1 is a bond or C 1-3 alkylene.

12 . A compound according to claim 10 wherein Z 1 is phenyl (unsubstituted or substituted by one substituent selected from NHSO 2 R 6 , CONR 7 R 8 , CF 3 , C 1-3 alkoxy, SO 2 R 6 , NHCOR 7 , SO 2 NR 7 R 8 , NR 7 R 8 ) or a 6 membered heterocyclic group which contains one nitrogen atom (which is unsubstituted or substituted one time by a group selected from C 1-3 alkyl, CH 2 phenyl, SO 2 R 6 , CONR 7 R 8 ).

13 . A compound according to claim 12 wherein Z 1 is a 6 membered heterocycle substituted by SO 2 R 6 .

14 . A compound according to claim 13 wherein the 6 membered heterocycle is 4-piperidyl.

15 . A compound according to claim 1 wherein R 1 is YZ and R 2 is H or Br.

16 . A compound according to claim 1 wherein R 1 is phenyl or Br and R 2 is Y 1 Z 1 .

17 . A compound according to claim 1 wherein R 2 is YZ and R 2 is Y 1 Z 1 .

18 . A compound as claimed in claim 1 , selected from the group consisting of:

5-phenyl-1H-indole-7-carboxamide;

5-(4-biphenylyl)-1H-indole-7-carboxamide;

5-{4-[(phenylmethyl)oxy]phenyl}-1H-indole-7-carboxamide;

5-{4-[(methylsulfonyl)amino]phenyl}-1H-indole-7-carboxamide;

5-[4-(acetylamino)phenyl]-1H-indole-7-carboxamide;

5-[3-(aminocarbonyl)phenyl]-1H-indole-7-carboxamide;

5-(4-chlorophenyl)-1H-indole-7-carboxamide;

5-[3-(acetylamino)phenyl]-1H-indole-7-carboxamide;

5-[3-(aminosulfonyl)phenyl]-1H-indole-7-carboxamide;

5-{3-[(dimethylamino)carbonyl]phenyl}-1H-indole-7-carboxamide;

5-(3-fluorophenyl)-1H-indole-7-carboxamide;

5-[3-(methyloxy)phenyl]-1H-indole-7-carboxamide;

5-(3-cyanophenyl)-1H-indole-7-carboxamide;

5-(3-hydroxyphenyl)-1H-indole-7-carboxamide;

5-(3-quinolinyl)-1H-indole-7-carboxamide;

5-(1-benzofuran-4-yl)-1H-indole-7-carboxamide;

5-(1,3-benzodioxol-5-yl)-1H-indole-7-carboxamide;

5-[(E)-2-phenylethenyl]-1H-indole-7-carboxamide;

5-(5-pyrimidinyl)-1H-indole-7-carboxamide;

5-(3-biphenylyl)-1H-indole-7-carboxamide;

5-(1-benzofuran-2-yl)-1H-indole-7-carboxamide;

5-(1-benzothien-2-yl)-1H-indole-7-carboxamide;

5-[3-(hydroxymethyl)phenyl]-1H-indole-7-carboxamide;

5-(2-naphthalenyl)-1H-indole-7-carboxamide;

5-(4-fluorophenyl)-1H-indole-7-carboxamide;

5-[6-(methyloxy)-3-pyridinyl]-1H-indole-7-carboxamide;

5-[4-(hydroxymethyl)phenyl]-1H-indole-7-carboxamide;

5-(3-chlorophenyl)-1H-indole-7-carboxamide;

5-(2-methylphenyl)-1H-indole-7-carboxamide;

5-{3-[(phenylmethyl)oxy]phenyl}-1H-indole-7-carboxamide;

5-(2-chlorophenyl)-1H-indole-7-carboxamide;

5-(3,5-dimethyl-4-isoxazolyl)-1H-indole-7-carboxamide;

5-{2-[(phenylmethyl)oxy]phenyl}-1H-indole-7-carboxamide;

5-(5-quinolinyl)-1H-indole-7-carboxamide;

5-(1-naphthalenyl)-1H-indole-7-carboxamide;

3-bromo-5-phenyl-1H-indole-7-carboxamide;

3-iodo-5-phenyl-1H-indole-7-carboxamide;

3,5-diphenyl-1H-indole-7-carboxamide;

3-{4-[(methylsulfonyl)amino]phenyl}-5-phenyl-1H-indole-7-carboxamide;

5-phenyl-3-(3-pyridinyl)-1H-indole-7-carboxamide;

3-(4-{[(2-aminoethyl)amino]carbonyl}phenyl)-5-phenyl-1H-indole-7-carboxamide;

3-[4-({[4-(methyloxy)-3-(4-methyl-1-piperazinyl)phenyl]amino}carbonyl)phenyl]-5-phenyl-1H-indole-7-carboxamide formate;

5-phenyl-3-[3-(trifluoromethyl)phenyl]-1H-indole-7-carboxamide;

5-bromo-3-iodo-1H-indole-7-carboxamide;

3-(1-ethyl-3-piperidinyl)-5-phenyl-1H-indole-7-carboxamide;

5-phenyl-3-(3-piperidinyl)-1H-indole-7-carboxamide;

5-phenyl-3-[1-(phenylmethyl)-3-piperidinyl]-1H-indole-7-carboxamide;

3-(1-cyclohexen-1-yl)-5-phenyl-1H-indole-7-carboxamide;

3-cyclohexyl-5-phenyl-1H-indole-7-carboxamide;

3-{1-[3-(methyloxy)phenyl]ethenyl}-5-phenyl-1H-indole-7-carboxamide;

5-phenyl-3-[1-(phenylmethyl)-1,2,3,6-tetrahydro-4-pyridinyl]-1H-indole-7-carbox-amide;

5-phenyl-3-(4-piperidinyl)-1H-indole-7-carboxamide;

3-{1-[(4-chlorophenyl)sulfonyl]-4-piperidinyl}-5-phenyl-1H-indole-7-carboxamide;

5-phenyl-3-[1-(propylsulfonyl)-4-piperidinyl]-1H-indole-7-carboxamide;

3-(1-acetyl-4-piperidinyl)-5-phenyl-1H-indole-7-carboxamide;

3-[1-(N,N-dimethyl-β-alanyl)-4-piperidinyl]-5-phenyl-1H-indole-7-carboxamide;

3-(1-ethyl-4-piperidinyl)-5-phenyl-1H-indole-7-carboxamide formate;

3-(1-methylpyrrolidin-2-yl)-5-phenyl-1H-indole-7-carboxamide;

3-[1-(ethylsulfonyl)pyrrolidin-3-yl]-5-phenyl-1H-indole-7-carboxamide;

3-[4-(methylsulfonyl)phenyl]-5-phenyl-1H-indole-7-carboxamide;

3-[3-(acetylamino)phenyl]-5-phenyl-1H-indole-7-carboxamide;

3-[4-(ethylsulfonyl)phenyl]-5-phenyl-1H-indole-7-carboxamide;

3-[3-(methylsulfonyl)phenyl]-5-phenyl-1H-indole-7-carboxamide;

3-(hexahydro-1H-azepin-4-yl)-5-phenyl-1H-indole-7-carboxamide;

3-[1-(ethylsulfonyl)hexahydro-1H-azepin-4-yl]-5-phenyl-1H-indole-7-carboxamide;

5-phenyl-3-[2-(4-pyridinyl)ethyl]-1H-indole-7-carboxamide;

3-{[1-(ethylsulfonyl)-4-piperidinylidene]methyl}-5-phenyl-1H-indole-7-carboxamide;

3-[1-(ethylsulfonyl)-4-piperidinyl]-5-[4-(hydroxymethyl)phenyl]-1H-indole-7-carboxamide;

5-phenyl-3-(3-piperidinylmethyl)-1H-indole-7-carboxamide;

5-phenyl-3-[2-(4-piperidinyl)ethyl]-1H-indole-7-carboxamide;

3-{2-[1-(ethylsulfonyl)-4-piperidinyl]ethyl}-5-phenyl-1H-indole-7-carboxamide;

3-{[1-(ethylsulfonyl)-3-piperidinyl]methyl}-5-phenyl-1H-indole-7-carboxamide;

3-{[1-(ethylsulfonyl)-4-piperidinyl]methyl}-5-phenyl-1H-indole-7-carboxamide;

3-{1-[(2)sulfonyl]-4-piperidinyl}-5-phenyl-1H-indole-7-carboxamide;

3-{1-[(4-fluorophenyl)sulfonyl]-4-piperidinyl}-5-phenyl-1H-indole-7-carboxamide;

3-{1-[(4-methylphenyl)sulfonyl]-4-piperidinyl}-5-phenyl-1H-indole-7-carboxamide;

3-{phenylsulfonyl-4-piperidinyl}-5-phenyl-1H-indole-7-carboxamide;

3-(1-{[4-(methyloxy)phenyl]sulfonyl}-4-piperidinyl)-5-phenyl-1H-indole-7-carboxamide;

3-[1-(ethanesulfonyl)-4-piperidinyl]-5-phenyl-1H-indole-7-carboxamide;

3-{1-[(2-propanesulfonyl]-4-piperidinyl}-5-phenyl-1H-indole-7-carboxamide;

5-phenyl-3-[1-(propanesulfonyl)-1,2,3,6-tetrahydro-4-pyridinyl]-1H-indole-7-carboxamide;

5-phenyl-3-(1-{[4-(trifluoromethyl)phenyl]sulfonyl}-4-piperidinyl)-1H-indole-7-carboxamide;

3-{1-[(2,4-dichlorophenyl)sulfonyl]-4-piperidinyl}-5-phenyl-1H-indole-7-carboxamide;

3-{1-[(3,4-dichlorophenyl)sulfonyl]-4-piperidinyl}-5-phenyl-1H-indole-7-carboxamide;

3-{1-[(ethylamino)carbonyl]-4-piperidinyl}-5-phenyl-1H-indole-7-carboxamide;

3-{1-[(4-1-piperazinyl)carbonyl]-4-piperidinyl}-5-phenyl-1H-indole-7-carboxamide;

5-(4-chlorophenyl)-3-[1-(propanesulfonyl)-4-piperidinyl]-1H-indole-7-carboxamide;

3-{1-[(4-fluorophenyl)sulfonyl]-4-piperidinyl}-5-(4-chlorophenyl)-1H-indole-7-carboxamide;

5-{4-[(methylsulfonyl)amino]phenyl}-3-[1-(phenylmethyl)-1,2,3,6-tetrahydro-4-pyridinyl]-1H-indole-7-carboxamide;

5-{4-[(methylsulfonyl)amino]phenyl}-3-(4-piperidinyl)-1H-indole-7-carboxamide;

5-bromo-3-[1-(ethanesulfonyl)-4-piperidinyl]-1H-indole-7-carboxamide;

3-[1-(ethanesulfonyl)-4-piperidinyl]-5-{4-[(methylsulfonyl)amino]phenyl}-1H-indole-7-carboxamide;

3-[1-(ethanesulfonyl)-4-piperidinyl]-5-(3-methylphenyl)-1H-indole-7-carboxamide;

3-[1-(ethylsulfonyl)-4-piperidinyl]-5-(2-thienyl)-1H-indole-7-carboxamide;

3-[1-(ethylsulfonyl)-4-piperidinyl]-5-(3-thienyl)-1H-indole-7-carboxamide;

3-[4-(methylsulfonyl)phenyl]-5-phenyl-1H-indole-7-carboxamide;

3-{4-[(dimethylamino)sulfonyl]phenyl}-5-phenyl-1H-indole-7-carboxamide;

3-{3-[(methylsulfonyl)amino]phenyl}-5-phenyl-1H-indole-7-carboxamide;

3-[1-(ethylsulfonyl)-4-piperidinyl]-5-{3-[(methylsulfonyl)amino]phenyl)-1H-indole-7-carboxamide;

5-[4-(acetylamino)phenyl]-3-[1-(ethylsulfonyl)-4-piperidinyl]-1H-indole-7-carboxamide;

5-{4-[(dimethylamino)sulfonyl]phenyl}-3-[1-(ethylsulfonyl)-4-piperidinyl]-1H-indole-7-carboxamide;

5-[3-(acetylamino)phenyl]-3-[1-(ethylsulfonyl)-4-piperidinyl]-1H-indole-7-carboxamide;

3-[1-(ethylsulfonyl)-4-piperidinyl]-5-(1H-pyrazol-4-yl)-1H-indole-7-carboxamide;

3-[1-(ethylsulfonyl)-4-piperidinyl]-5-[3-(hydroxymethyl)phenyl]-1H-indole-7-carboxamide;

5-(2,4-difluorophenyl)-3-[1-(ethylsulfonyl)-4-piperidinyl]-1H-indole-7-carboxamide;

3-[1-(ethylsulfonyl)-4-piperidinyl]-5-[4-(methyloxy)phenyl]-1H-indole-7-carboxamide;

3-[1-(ethylsulfonyl)-4-piperidinyl]-5-(4-fluoro-2-methylphenyl)-1H-indole-7-carboxamide;

3-[1-(ethylsulfonyl)-4-piperidinyl]-5-(4-fluorophenyl)-1H-indole-7-carboxamide;

5-(4-biphenylyl)-3-[1-(ethylsulfonyl)-4-piperidinyl]-1H-indole-7-carboxamide;

5-[4-(1,1-dimethylethyl)phenyl]-3-[1-(ethylsulfonyl)-4-piperidinyl]-1H-indole-7-carboxamide;

3-[1-(ethylsulfonyl)-4-piperidinyl]-5-(4-methylphenyl)-1H-indole-7-carboxamide;

3-[1-(ethylsulfonyl)-4-piperidinyl]-5-(4-pyridinyl)-1H-indole-7-carboxamide;

3-[1-(ethylsulfonyl)-4-piperidinyl]-5-(6-fluoro-3-pyridinyl)-1H-indole-7-carboxamide;

3-[1-(ethylsulfonyl)-4-piperidinyl]-5-(6-methyl-3-pyridinyl)-1H-indole-7-carboxamide;

3-[1-(ethylsulfonyl)-4-piperidinyl]-5-(4-methyl-3-pyridinyl)-1H-indole-7-carboxamide;

3-[1-(ethylsulfonyl)-4-piperidinyl]-5-[6-(methyloxy)-3-pyridinyl]-1H-indole-7-carboxamide;

5-phenyl-3-(N-acetyl-3-piperidinylmethyl)-1H-indole-7-carboxamide;

5-[3-(ethyloxy)phenyl]-3-[1-(ethylsulfonyl)-4-piperidinyl]-1H-indole-7-carboxamide;

3-[1-(ethylsulfonyl)-4-piperidinyl]-5-(2-fluorophenyl)-1H-indole-7-carboxamide;

3-[1-(ethylsulfonyl)-4-piperidinyl]-5-[3-(trifluoromethyl)phenyl]-1H-indole-7-carboxamide;

3-[1-(ethylsulfonyl)-4-piperidinyl]-5-[4-(trifluoromethyl)phenyl]-1H-indole-7-carboxamide;

3-[1-(ethylsulfonyl)-4-piperidinyl]-5-(3-fluorophenyl)-1H-indole-7-carboxamide;

5-(3,5-dichlorophenyl)-3-[1-(ethylsulfonyl)-4-piperidinyl]-1H-indole-7-carboxamide;

5-(3,4-difluorophenyl)-3-[1-(ethylsulfonyl)-4-piperidinyl]-1H-indole-7-carboxamide;

3-bromo-5-{3-[(dimethylamino)carbonyl]phenyl}-1H-indole-7-carboxamide;

5-[2,6-bis(methyloxy)phenyl]-3-bromo-1H-indole-7-carboxamide;

3-bromo-5-(4-fluoro-2-methylphenyl)-1H-indole-7-carboxamide;

3-bromo-5-[5-fluoro-2-(methyloxy)phenyl]-1H-indole-7-carboxamide;

3-bromo-5-(3-quinolinyl)-1H-indole-7-carboxamide trifluoroacetate;

3-bromo-5-(5-quinolinyl)-1H-indole-7-carboxamide trifluoroacetate;

5-[2,5-bis(methyloxy)phenyl]-3-bromo-1H-indole-7-carboxamide;

3-bromo-5-(2-fluorophenyl)-1H-indole-7-carboxamide;

5-[2,4-bis(methyloxy)phenyl]-3-bromo-1H-indole-7-carboxamide;

3-bromo-5-[2-(methyloxy)-3-pyridinyl]-1H-indole-7-carboxamide trifluoroacetate;

3-bromo-5-[2,3,4-tris(methyloxy)phenyl]-1H-indole-7-carboxamide;

3-{1-[(4-chloro-2,5-dimethylphenyl)sulfonyl]-4-piperidinyl}-5-phenyl-1H-indole-7-carboxamide;

3-(1-{[5-bromo-2-(methyloxy)phenyl]sulfonyl}-4-piperidinyl)-5-phenyl-1H-indole-7-carboxamide;

3-{1-[(5-fluoro-2-methylphenyl)sulfonyl]-4-piperidinyl}-5-phenyl-1H-indole-7-carboxamide;

3-{1-[(3-fluorophenyl)sulfonyl]-4-piperidinyl}-5-phenyl-1H-indole-7-carboxamide;

5-phenyl-3-(1-{[2,4,6-tris(1-methylethyl)phenyl]sulfonyl}-4-piperidinyl)-1H-indole-7-carboxamide;

3-(1-{[4-(1,1-dimethylpropyl)phenyl]sulfonyl}-4-piperidinyl)-5-phenyl-1H-indole-7-carboxamide;

3-{1-[(2-methylphenyl)sulfonyl]-4-piperidinyl}-5-phenyl-1H-indole-7-carboxamide;

3-{1-[(2-iodophenyl)sulfonyl]-4-piperidinyl}-5-phenyl-1H-indole-7-carboxamide;

3-{1-[(4-pentylphenyl)sulfonyl]-4-piperidinyl}-5-phenyl-1H-indole-7-carboxamide;

5-phenyl-3-{1-[(4-propylphenyl)sulfonyl]-4-piperidinyl}-1H-indole-7-carboxamide;

3-{1-[(2,4-difluorophenyl)sulfonyl]-4-piperidinyl}-5-phenyl-1H-indole-7-carboxamide;

3-{1-[(2,5-dimethylphenyl)sulfonyl]-4-piperidinyl}-5-phenyl-1H-indole-7-carboxamide;

3-1-[(4-ethylphenyl)sulfonyl]-4-piperidinyl}-5-phenyl-1H-indole-7-carboxamide;

3-{1-[(3-methylphenyl)sulfonyl]-4-piperidinyl}-5-phenyl-1H-indole-7-carboxamide;

3-{1-[(4-{[2-(methyloxy)phenyl]oxy}phenyl)sulfonyl]-4-piperidinyl}-5-phenyl-1H-indole-7-carboxamide;

3-{1-[(4-{[4-(methyloxy)phenyl]oxy}phenyl)sulfonyl]-4-piperidinyl}-5-phenyl-1H-indole-7-carboxamide;

3-[1-((3-[(4-fluorophenyl)oxy]phenyl}sulfonyl)-4-piperidinyl]-5-phenyl-1H-indole-7-carboxamide;

3-{1-[(3-{[2-(methyloxy)phenyl]oxy}phenyl)sulfonyl]-4-piperidinyl}-5-phenyl-1H-indole-7-carboxamide;

3-[1-((4-[(4-chlorophenyl)oxy]phenyl}sulfonyl)-4-piperidinyl]-5-phenyl-1H-indole-7-carboxamide;

3-{1-[(3-{[4-(methyloxy)phenyl]oxy}phenyl)sulfonyl]-4-piperidinyl}-5-phenyl-1H-indole-7-carboxamide;

5-phenyl-3-(1-{[3-(phenyloxy)phenyl]sulfonyl}-4-piperidinyl)-1H-indole-7-carboxamide;

3-[1-({3-[(4-chlorophenyl)oxy]phenyl}sulfonyl)-4-piperidinyl]-5-phenyl-1H-indole-7-carboxamide;

3-[1-({4-[(2-methylphenyl)oxy]phenyl}sulfonyl)-4-piperidinyl]-5-phenyl-1H-indole-7-carboxamide;

3-{1-[(4′-chloro-4-biphenylyl)sulfonyl]-4-piperidinyl}-5-phenyl-1H-indole-7-carboxamide;

3-[1-((3-[(2-methylphenyl)oxy]phenyl}sulfonyl)-4-piperidinyl]-5-phenyl-1H-indole-7-carboxamide;

3-[1-((3-[(2-chlorophenyl)oxy]phenyl}sulfonyl)-4-piperidinyl]-5-phenyl-1H-indole-7-carboxamide;

3-{1-[(5-chloro-1-naphthalenyl)sulfonyl]-4-piperidinyl}-5-phenyl-1H-indole-7-carboxamide;

3-(1-{[4′-(methyloxy)-3-biphenylyl]sulfonyl}-4-piperidinyl)-5-phenyl-1H-indole-7-carboxamide;

3-[1-(3-biphenylylsulfonyl)-4-piperidinyl]-5-phenyl-1H-indole-7-carboxamide;

3-(1-{[(4-fluorophenyl)methyl]sulfonyl}-4-piperidinyl)-5-phenyl-1H-indole-7-carboxamide;

3-{1-[(5-chloro-2-naphthalenyl)sulfonyl]-4-piperidinyl}-5-phenyl-1H-indole-7-carboxamide;

3-(1-{[4′-(methyloxy)-4-biphenylyl]sulfonyl}-4-piperidinyl)-5-phenyl-1H-indole-7-carboxamide;

5-(2-fluorophenyl)-1H-indole-7-carboxamide;

5-(3-{[(2,2-dimethylpropyl)amino]carbonyl}phenyl)-1H-indole-7-carboxamide;

5-(3-{[(1-methylethyl)amino]carbonyl}phenyl)-1H-indole-7-carboxamide;

5-(4-{[(2,2-dimethylpropyl)amino]carbonyl}phenyl)-1H-indole-7-carboxamide;

5-{4-[(propylamino)carbonyl]phenyl}-1H-indole-7-carboxamide;

5-(4-{[(1-methylethyl)amino]carbonyl}phenyl)-1H-indole-7-carboxamide;

5-{4-[(diethylamino)carbonyl]phenyl}-1H-indole-7-carboxamide;

3-[1-(methylsulfonyl)-1,2,3,6-tetrahydro-4-pyridinyl]-5-phenyl-1H-indole-7-carboxamide;

3-(3-oxocyclopentyl)-5-phenyl-1H-indole-7-carboxamide;

5-phenyl-3-{3-[(phenylmethyl)amino]cyclopentyl}-1H-indole-7-carboxamide;

3-(3-aminocyclopentyl)-5-phenyl-1H-indole-7-carboxamide;

3-{3-[(ethylsulfonyl)amino]cyclopentyl}-5-phenyl-1H-indole-7-carboxamide;

5-bromo-3-[1-(propylsulfonyl)-4-piperidinyl]-1H-indole-7-carboxamide;

5-bromo-3-(3-pyridinyl)-1H-indole-7-carboxamide;

5-bromo-3-[1-(methylsulfonyl)-1,2,3,6-tetrahydro-4-pyridinyl]-1H-indole-7-carboxamide;

3-[(4-hydroxyphenyl)methyl]-5-phenyl-1H-indole-7-carboxamide;

5-bromo-1H-indole-7-carboxamide;

5-(4-chlorophenyl)1H-indole-7-carboxamide;

5-bromo-3 (4-piperidinyl)1H-indole-7-carboxamide;

or a salt, solvate, or physiologically functional derivative thereof.

19 . A pharmaceutical composition, comprising a compound as claimed in claim 1 , or a salt, solvate, or a physiologically functional derivative thereof and one or more of pharmaceutically acceptable carriers, diluents and excipients.

20 . A compound as claimed in claim 1 , or a salt, solvate, or a physiologically functional derivative thereof for use in therapy.

21 . A compound according to claim 1 for use in the treatment of a disorder mediated by inappropriate kinase activity.

22 . A compound according to claim 1 for use in the treatment of a disorder mediated by inappropriate IKK2 activity.

23 . A method of treating a disorder in a mammal, said disorder being mediated by inappropriate kinase activity, comprising administering to said mammal a compound as claimed in claim 1 , or a salt, solvate, or a physiologically functional derivative thereof.

24 . A method according to claim 23 wherein the inappropriate kinase activity is inappropriate IKK2 activity.

25 . A method according to claim 24 wherein the disorder mediated by inappropriate IKK2 activity is inflammatory and tissue repair disorders, particularly rheumatoid arthritis, inflammatory bowel disease, asthma and COPD (chronic obstructive pulmonary disease); osteoarthritis, osteoporosis and fibrotic diseases; dermatosis, including psoriasis, atopic dermatitis and ultraviolet radiation (UV)-induced skin damage; autoimmune diseases including systemic lupus eythematosus, multiple sclerosis, psoriatic arthritis, alkylosing spondylitis, tissue and organ rejection, Alzheimer's disease, stroke, atherosclerosis, restonosis, diabetes, glomerulonephritis, cancer, including Hodgkins disease, cachexia, inflammation associated with infection and certain viral infections, including acquired immune deficiency syndrome (AIDS), adult respiratory distress syndrome, and Ataxia Telangiestasia, comprising administering a therapeutically effective amount to a mammal of a compound of formula (I), or a salt, solvate or pharmaceutically functional derivative thereof.

26 - 38 . (canceled)